Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLITone Birch in Seasonal Birch Pollen Induced Rhinoconjunctivitis
NCT00310466Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Jun 2005
- Primary completion
- Aug 2006
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 3 trial of birch pollen allergen extract in allergic rhinoconjunctivitis (ARC), sponsored by ALK-Abelló. Started Jun 2005; status: completed.
02
Drugs
birch pollen allergen extract
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00310466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310466.